Venom immunotherapy products: supply update
February 2019
Stallergenes Greer is continuing efforts to secure the supply of registered ALBEY® venom products to Australia and New Zealand. In the meantime, replacement Hymenoptera® venom products and replacement sterile Greer diluents have been authorised for supply in Australia and New Zealand by Medsafe and the TGA under S19A(1) of the Therapeutic Goods Act.
Please find below an update of Hymenoptera® venom product availability in Australia and New Zealand.
Honey Bee venom
• In stock in Australia
• Out of stock in New Zealand (ETA: >1 week)
Paper Wasp venom
• In stock in Australia
• Out of stock in New Zealand (ETA: >1 week)
Yellow Jacket venom
• In stock in Australia
• Out of stock in New Zealand (ETA: >1 week)
Registered and replacement venom products: differences in external appearance
Whilst the external appearance of the replacement products and registered products differ, they are identical in terms of the:
• drug substance and materials;
• equipment and method of manufacture of drug substance and finished product; and
• immediate container and closure.
The registered and replacement products are both supplied by the manufacturer in sterile vials within tamper-evident packaging: within sealed external plastic packaging in the case of the replacement Greer diluents and within vials with breakable caps in the case of the registered ALBEY diluents. If you remove these products from their original tamper-evident packaging to provide to third parties for administration, please explain the difference in the external appearance of the product and refer to this communication if necessary.
Further assistance
Please contact Stallergenes Greer according to the information set out below:
• For order enquiries:
o in Australia, please contact DHL on 1800 077 421 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.
o in New Zealand, please contact Mary McIntyre by email at This email address is being protected from spambots. You need JavaScript enabled to view it.
• For medical information enquiries, please contact Dr. Martin Rees (APAC Regional Medical Director) by email at This email address is being protected from spambots. You need JavaScript enabled to view it.
• To report adverse events, please contact Stallergenes Greer on 1800 824 166 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.
For guidance on how to make decisions about the appropriate care for patients currently receiving venom immunotherapy, and measures to avoid interruptions to therapy in high-risk patients, you may wish to refer to the following websites:
- ASCIA website members section www.allergy.org.au/members/allergen-immunotherapy
- AAAAI/ACAAI Joint Venom Extract Shortage Task Force Report www.annallergy.org/article/S1081-1206(17)30102-3/fulltext
Content updated 11 February 2019
